The ETERNAL project provides the setting for a new podcast episode producede by New Scientist with teh support of UK Government about UK-Spanish collaboration. The podcast features an extended interview with researchers from IRIS Technology Solutions who are pioneering digitalisation elements within ETERNAL's industrial case studies, inlcuding those with Arcinova/Quotient Sciences and Astra Zeneca.

ETERNAL's 7th newsletter brings news of newly published research results reporting how the enzymatic (laccase-mediated) transformation has been used to breakdown the antidepressant trazodone hydrochloride and its associated by-products, along with several new resources and routes to find out more about the broad impact being achieved across ETERNAL's industrial case studies. You can also find out more about the social and behavioural aspects of change being explored in the project’s Change Labs through interventions for healthcare practioners and patients.